| 225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study M Sathekge, F Bruchertseifer, O Knoesen, F Reyneke, I Lawal, T Lengana, ... European journal of nuclear medicine and molecular imaging 46, 129-138, 2019 | 316 | 2019 |
| Intraindividual comparison of 18F-PSMA-1007 and 18F-DCFPyL PET/CT in the prospective evaluation of patients with newly diagnosed prostate carcinoma: a pilot study FL Giesel, L Will, I Lawal, T Lengana, C Kratochwil, M Vorster, O Neels, ... Journal of Nuclear Medicine 59 (7), 1076-1080, 2018 | 184 | 2018 |
| Predictors of overall and disease-free survival in metastatic castration-resistant prostate cancer patients receiving 225Ac-PSMA-617 radioligand therapy M Sathekge, F Bruchertseifer, M Vorster, IO Lawal, O Knoesen, ... Journal of Nuclear Medicine 61 (1), 62-69, 2020 | 166 | 2020 |
| 68Ga-PSMA PET/CT replacing bone scan in the initial staging of skeletal metastasis in prostate cancer: a fait accompli? T Lengana, IO Lawal, TG Boshomane, GO Popoola, KMG Mokoala, ... Clinical genitourinary cancer 16 (5), 392-401, 2018 | 115 | 2018 |
| F-18 FDG PET/CT imaging of cardiac and vascular inflammation and infection I Lawal, M Sathekge British Medical Bulletin 120 (1), 55-74, 2016 | 62 | 2016 |
| Diagnostic sensitivity of Tc‐99m HYNIC PSMA SPECT/CT in prostate carcinoma: A comparative analysis with Ga‐68 PSMA PET/CT IO Lawal, AO Ankrah, NP Mokgoro, M Vorster, A Maes, MM Sathekge The Prostate 77 (11), 1205-1212, 2017 | 59 | 2017 |
| Metabolic imaging of infection I Lawal, JR Zeevaart, T Ebenhan, A Ankrah, M Vorster, HG Kruger, ... Journal of Nuclear Medicine 58 (11), 1727-1732, 2017 | 54 | 2017 |
| Monitoring response to therapy MM Sathekge, AO Ankrah, I Lawal, M Vorster Seminars in nuclear medicine 48 (2), 166-181, 2018 | 46 | 2018 |
| Treatment of brain metastases of castration-resistant prostate cancer with 225Ac-PSMA-617 MM Sathekge, F Bruchertseifer, IO Lawal, M Vorster, O Knoesen, ... European Journal of Nuclear Medicine and Molecular Imaging 46, 1756-1757, 2019 | 41 | 2019 |
| mCRPC patients receiving 225Ac-PSMA-617 therapy in the post–androgen deprivation therapy setting: response to treatment and survival analysis M Sathekge, F Bruchertseifer, M Vorster, IO Lawal, O Knoesen, ... Journal of Nuclear Medicine 63 (10), 1496-1502, 2022 | 38 | 2022 |
| Global experience with PSMA-based alpha therapy in prostate cancer MM Sathekge, F Bruchertseifer, M Vorster, A Morgenstern, IO Lawal European Journal of Nuclear Medicine and Molecular Imaging 49 (1), 30-46, 2021 | 38 | 2021 |
| 68Ga-PSMA-11 PET/CT in primary staging of prostate carcinoma: preliminary results on differences between black and white South-Africans M Sathekge, T Lengana, A Maes, M Vorster, JR Zeevaart, I Lawal, ... European Journal of Nuclear Medicine and Molecular Imaging 45, 226-234, 2018 | 33 | 2018 |
| Molecular imaging in musculoskeletal infections with 99mTc-UBI 29-41 SPECT/CT M Sathekge, O Garcia-Perez, D Paez, N El-Haj, T Kain-Godoy, I Lawal, ... Annals of Nuclear Medicine 32, 54-59, 2018 | 33 | 2018 |
| COVID-19 is a multi-organ aggressor: epigenetic and clinical marks MM Kgatle, IO Lawal, G Mashabela, TMG Boshomane, PC Koatale, ... Frontiers in immunology 12, 752380, 2021 | 29 | 2021 |
| Arterial inflammation in young patients with human immunodeficiency virus infection: a cross-sectional study using F-18 FDG PET/CT IO Lawal, AO Ankrah, GO Popoola, T Lengana, MM Sathekge Journal of Nuclear Cardiology 26 (4), 1258-1265, 2019 | 29 | 2019 |
| PSMA theranostics: science and practice K Mokoala, I Lawal, T Lengana, M Kgatle, FL Giesel, M Vorster, ... Cancers 13 (15), 3904, 2021 | 27 | 2021 |
| 18F-FDG PET/CT as a noninvasive biomarker for assessing adequacy of treatment and predicting relapse in patients treated for pulmonary tuberculosis IO Lawal, BP Fourie, M Mathebula, I Moagi, T Lengana, N Moeketsi, ... Journal of Nuclear Medicine 61 (3), 412-417, 2020 | 27 | 2020 |
| Hematologic toxicity profile and efficacy of [225Ac] Ac-PSMA-617 α-radioligand therapy of patients with extensive skeletal metastases of castration-resistant prostate cancer IO Lawal, A Morgenstern, M Vorster, O Knoesen, J Mahapane, ... European Journal of Nuclear Medicine and Molecular Imaging 49 (10), 3581-3592, 2022 | 26 | 2022 |
| A prospective intra-individual comparison of [68Ga]Ga-PSMA-11 PET/CT, [68Ga]Ga-NODAGAZOL PET/CT, and [99mTc]Tc-MDP bone scintigraphy for … IO Lawal, KMG Mokoala, J Mahapane, J Kleyhans, M Meckel, M Vorster, ... European Journal of Nuclear Medicine and Molecular Imaging 48, 134-142, 2021 | 26 | 2021 |
| Prostate-specific membrane antigen-targeted endoradiotherapy in metastatic prostate cancer IO Lawal, F Bruchertseifer, M Vorster, A Morgenstern, MM Sathekge Current Opinion in Urology 30 (1), 98-105, 2020 | 26 | 2020 |
Mike SathekgeUniversity of Pretoria在 up.ac.za 的电子邮件经过验证
